73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Oncogenic driver FGFR3-TACC3 requires 5 coiled-coil heptads for activation and disulfide bonds for stability

Oncogenic driver FGFR3-TACC3 requires 5 coiled-coil heptads for activation and disulfide bonds for stability

by Impact Journals LLCFGFR3-TACC3 fusion proteins. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28359FGFR3-TACC3 represents an oncogenic fusion protein frequently identified in gliobl

Oncogenic driver FGFR3-TACC3 requires 5 coiled-coil heptads for activation and disulfide bonds for stability

by Impact Journals LLCFGFR3-TACC3 fusion proteins. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28359FGFR3-TACC3 represents an oncogenic fusion protein frequently identified in gliobl
New strategy for treating the most aggressive type of brain cancer

New strategy for treating the most aggressive type of brain cancer

by Maria Fernanda Ziegler,FAPESPCredit: CC0 Public DomainResearchers from the University of São Paulo (USP) in Brazil have developed a strategy for treating the most aggressive type of brain can

New strategy for treating the most aggressive type of brain cancer

by Maria Fernanda Ziegler,FAPESPCredit: CC0 Public DomainResearchers from the University of São Paulo (USP) in Brazil have developed a strategy for treating the most aggressive type of brain can
Researchers find an epigenetic key that unlocks common deadly cancers

Researchers find an epigenetic key that unlocks common deadly cancers

by Katherine Fenz,Rockefeller UniversityLesions (in green) akin to basal cell carcinoma that were induced by SOX9 in the epidermis. Abnormal differentiation is shown in red, and blue marks cell

Researchers find an epigenetic key that unlocks common deadly cancers

by Katherine Fenz,Rockefeller UniversityLesions (in green) akin to basal cell carcinoma that were induced by SOX9 in the epidermis. Abnormal differentiation is shown in red, and blue marks cell
Discovery of a gene that could be key for reducing breast cancer risk

Discovery of a gene that could be key for reducing breast cancer risk

by University of OtagoCharacterization of SULT1A1. a Genomic viewer (UCSC) of the SULT1A1 gene locus with copy number variants; deletion (red) and duplication (blue). b Dosage effect in breast tu

Discovery of a gene that could be key for reducing breast cancer risk

by University of OtagoCharacterization of SULT1A1. a Genomic viewer (UCSC) of the SULT1A1 gene locus with copy number variants; deletion (red) and duplication (blue). b Dosage effect in breast tu
Novel biomarker found in ovarian cancer patients can predict response to therapy

Novel biomarker found in ovarian cancer patients can predict response to therapy

by University of Chicago Medical CenterTumor-specific expression of CT45 stimulates the patient's immune system to fight the cancer and improves the efficacy of platinum-based chemotherapy. C

Novel biomarker found in ovarian cancer patients can predict response to therapy

by University of Chicago Medical CenterTumor-specific expression of CT45 stimulates the patient's immune system to fight the cancer and improves the efficacy of platinum-based chemotherapy. C
Research links development of childhood leukaemia to mistakes by the immune system

Research links development of childhood leukaemia to mistakes by the immune system

by University of LeedsA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/WikipediaGenetic mutations that drive the

Research links development of childhood leukaemia to mistakes by the immune system

by University of LeedsA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/WikipediaGenetic mutations that drive the
Finally, a potential new approach against KRAS-driven lung cancer

Finally, a potential new approach against KRAS-driven lung cancer

by CU Anschutz Medical CampusAlison Bauer, PhD, and colleagues identify MUC5AC as a new target in KRAS-driven lung cancer. Credit: University of Colorado Cancer CenterThe previous decade has seen

Finally, a potential new approach against KRAS-driven lung cancer

by CU Anschutz Medical CampusAlison Bauer, PhD, and colleagues identify MUC5AC as a new target in KRAS-driven lung cancer. Credit: University of Colorado Cancer CenterThe previous decade has seen
A new nutrition-screening tool for the oncologic population

A new nutrition-screening tool for the oncologic population

byScience China PressVenn plots of three screening tools and malnutrition defined by PG-SGA. Malnutrition was defined as a PG-SGA score of ≥4. The malnutrition risk in MST was defined as an MST

A new nutrition-screening tool for the oncologic population

byScience China PressVenn plots of three screening tools and malnutrition defined by PG-SGA. Malnutrition was defined as a PG-SGA score of ≥4. The malnutrition risk in MST was defined as an MST
Study finds outcomes after stem cell transplant in elderly patients with AML have improved since 2000

Study finds outcomes after stem cell transplant in elderly patients with AML have improved since 2000

by American Association for Cancer ResearchCredit: CC0 Public DomainAccording to astudypublished inClinical Cancer Research, among patients over 65 who received an allogeneic he

Study finds outcomes after stem cell transplant in elderly patients with AML have improved since 2000

by American Association for Cancer ResearchCredit: CC0 Public DomainAccording to astudypublished inClinical Cancer Research, among patients over 65 who received an allogeneic he
Balance of 'stop' and 'go' signaling could be key to cancer immunotherapy response

Balance of 'stop' and 'go' signaling could be key to cancer immunotherapy response

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainA crucial signaling pathway that can tell the immune system to fight off cancer can also be co-opted by ca

Balance of 'stop' and 'go' signaling could be key to cancer immunotherapy response

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainA crucial signaling pathway that can tell the immune system to fight off cancer can also be co-opted by ca
How a bereaved mom is helping researchers improve palliative care

How a bereaved mom is helping researchers improve palliative care

by Erin Digitale,Stanford University Medical CenterJamila Hassan participated in research about end-of-life care for children after losing her son Omar to cancer in 2012. Credit: Courtesy of the

How a bereaved mom is helping researchers improve palliative care

by Erin Digitale,Stanford University Medical CenterJamila Hassan participated in research about end-of-life care for children after losing her son Omar to cancer in 2012. Credit: Courtesy of the